Dashboard
Manage Tickers

LFMDLifeMD, Inc.

Nasdaq lifemd.com


$ 12.42 $ -0.09 (-0.72 %)    

Monday, 06-May-2024 15:59:59 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 440.03 $ 3.08 (0.7 %)
DIA $ 388.40 $ 1.63 (0.42 %)
SPY $ 516.34 $ 5.05 (0.99 %)
TLT $ 90.16 $ 0.32 (0.36 %)
GLD $ 215.21 $ 2.25 (1.06 %)
$ 12.51
$ 12.34
$ 0.00 x 0
$ 12.41 x 100
$ 12.11 - $ 12.44
$ 1.46 - $ 12.80
870,408
na
424.15M
$ -1.27
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-11-2024 12-31-2023 10-K
2 11-08-2023 09-30-2023 10-Q
3 08-09-2023 06-30-2023 10-Q
4 05-12-2023 03-31-2023 10-Q
5 03-22-2023 12-31-2022 10-K
6 11-10-2022 09-30-2022 10-Q
7 08-11-2022 06-30-2022 10-Q
8 05-13-2022 03-31-2022 10-Q
9 03-07-2022 12-31-2021 10-K
10 11-10-2021 09-30-2021 10-Q
11 08-13-2021 06-30-2021 10-Q
12 05-14-2021 03-31-2021 10-Q
13 03-30-2021 12-31-2020 10-K
14 11-16-2020 09-30-2020 10-Q
15 08-14-2020 06-30-2020 10-Q
16 05-19-2020 03-31-2020 10-Q
17 03-30-2020 12-31-2019 10-K
18 11-14-2019 09-30-2019 10-Q
19 08-14-2019 06-30-2019 10-Q
20 05-15-2019 03-31-2019 10-Q
21 04-01-2019 12-31-2018 10-K
22 11-14-2018 09-30-2018 10-Q
23 08-17-2018 06-30-2018 10-Q
24 05-15-2018 03-31-2018 10-Q
25 04-02-2018 12-31-2017 10-K
26 11-14-2017 09-30-2017 10-Q
27 08-14-2017 06-30-2017 10-Q
28 07-07-2017 03-31-2017 10-Q
29 05-24-2017 12-31-2016 10-K
30 11-14-2016 09-30-2016 10-Q
31 08-15-2016 06-30-2016 10-Q
32 05-16-2016 03-31-2016 10-Q
33 03-30-2016 12-31-2015 10-K
34 11-13-2015 09-30-2015 10-Q
35 08-13-2015 06-30-2015 10-Q
36 05-14-2015 03-31-2015 10-Q
37 03-30-2015 12-31-2014 10-K
38 11-14-2014 09-30-2014 10-Q
39 08-14-2014 06-30-2014 10-Q
40 05-15-2014 03-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

lifemd-becomes-the-first-virtual-primary-care-provider-to-elevate-glp-1-patient-care-with-real-time-at-home-monitoring-of-blood-pressure-and-body-composition
LifeMD Becomes The First Virtual Primary C...
05/02/2024 12:09:23

LifeMD, Inc.® (NASDAQ:LFMD), a leading provider of virtual primary care services, and Withings Health Solutions, a leader in di...

btig-maintains-buy-on-lifemd-raises-price-target-to-14
BTIG Maintains Buy on LifeMD, Raises Price...
04/23/2024 11:31:25

BTIG analyst David Larsen maintains LifeMD (NASDAQ:LFMD) with a Buy and raises the price target from $13 to $14.

btig-maintains-buy-on-lifemd-raises-price-target-to-13
BTIG Maintains Buy on LifeMD, Raises Price...
03/15/2024 12:16:11

BTIG analyst David Larsen maintains LifeMD (NASDAQ:LFMD) with a Buy and raises the price target from $11 to $13.

craig-hallum-maintains-buy-on-lifemd-raises-price-target-to-15
Craig-Hallum Maintains Buy on LifeMD, Rais...
03/12/2024 15:25:44

Craig-Hallum analyst Alex Fuhrman maintains LifeMD (NASDAQ:LFMD) with a Buy and raises the price target from $10 to $15.

b-riley-securities-reiterates-buy-on-lifemd-raises-price-target-to-12
B. Riley Securities Reiterates Buy on Life...
03/12/2024 13:45:14

B. Riley Securities analyst William Woods reiterates LifeMD (NASDAQ:LFMD) with a Buy and raises the price target from $11 to...

cantor-fitzgerald-maintains-overweight-on-lifemd-raises-price-target-to-11
Cantor Fitzgerald Maintains Overweight on ...
03/12/2024 13:22:36

Cantor Fitzgerald analyst Sarah James maintains LifeMD (NASDAQ:LFMD) with a Overweight and raises the price target from $9 t...

lifemd-shares-are-trading-higher-after-the-company-reported-better-than-expected-q4-financial-results-and-issued-guidance
LifeMD shares are trading higher after the...
03/12/2024 10:43:49

hc-wainwright--co-reiterates-buy-on-lifemd-maintains-12-price-target
HC Wainwright & Co. Reiterates Buy on Life...
03/12/2024 10:18:39

HC Wainwright & Co. analyst Yi Chen reiterates LifeMD (NASDAQ:LFMD) with a Buy and maintains $12 price target.

12-health-care-stocks-moving-in-mondays-after-market-session
12 Health Care Stocks Moving In Monday's A...
03/11/2024 21:34:44

lifemd-sees-q1-revenue-42m-43m-vs-4254m-est-fy24-revenue-200m-vs-19152m-est-prior-est-195m-205m
LifeMD Sees Q1 Revenue $42M-$43M vs $42.54...
03/11/2024 20:25:40

recap-lifemd-q4-earnings
Recap: LifeMD Q4 Earnings
03/11/2024 20:15:07

lifemd-q4-2023-adj-eps-015-beats-014-estimate-sales-44860m-beat-40494m-estimate
LifeMD Q4 2023 Adj EPS $0.15 Beats $(0.14)...
03/11/2024 20:14:35

LifeMD (NASDAQ:LFMD) reported quarterly earnings of $0.15 per share which beat the analyst consensus estimate of $(0.14) by 207...

earnings-scheduled-for-march-11-2024
Earnings Scheduled For March 11, 2024
03/11/2024 08:56:22

Companies Reporting Before The Bell • Ballard Power Systems (NASDAQ:BLDP) is estimated to report quarterly loss at $0.13 per s...

earnings-outlook-for-lifemd
Earnings Outlook For LifeMD
03/08/2024 15:01:29

100-invested-in-lifemd-5-years-ago-would-be-worth-this-much-today
$100 Invested In LifeMD 5 Years Ago Would ...
01/19/2024 20:30:15

if-you-invested-100-in-this-stock-5-years-ago-you-would-have-800-today
If You Invested $100 In This Stock 5 Years...
01/18/2024 14:00:32

hc-wainwright--co-maintains-buy-on-lifemd-raises-price-target-to-12
HC Wainwright & Co. Maintains Buy on LifeM...
01/11/2024 12:53:17

HC Wainwright & Co. analyst Yi Chen maintains LifeMD (NASDAQ:LFMD) with a Buy and raises the price target from $10 to $12.

lifemd-expects-2024-revenue-195m-205m-vs-18118m-est
LifeMD Expects 2024 Revenue $195M-$205M vs...
01/08/2024 13:06:56

why-mobileye-global-shares-are-trading-lower-by-over-23-here-are-other-stocks-moving-in-thursdays-mid-day-session
Why Mobileye Global Shares Are Trading Low...
01/04/2024 18:37:44

Shares of Mobileye Global Inc. (NASDAQ: MBLY) fell sharply during Thursday’s session after the company issued preliminary FY23...

12-health-care-stocks-moving-in-thursdays-intraday-session
12 Health Care Stocks Moving In Thursday's...
01/04/2024 17:31:11

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION